Cellectis acquires delivery system from Diatos
13 October 2009
Simon Varcoe
Please Login to read the full article.
13 October 2009
Simon Varcoe
simon.varcoe@informa.com
Cellectis has acquired Diatos's Vectocell intracellular delivery technology to optimise the efficacy of its drug candidates.
The technology, which is based on the fusion of a therapeutic protein and an antibody-derived peptide, may improve a compound's performance by enabling specific entry...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Renamed Lipoxen turns to Russia to derisk biotech development
- US Capitol Capsule: Supreme Court takes another stab at refining US patent law
- ImmusanT start-up raises $20m to advance therapeutic vaccine for coeliac disease
- US Capitol Capsule: After muddled messages, Republicans unite again on Medicare overhaul
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
